Insulet Corporation
PODD Healthcare Medical Devices
Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow PODD
Insulet Corporation (PODD) Net income
Insulet Corporation's net income for fiscal 2025 was $247.1M, down 40.9% from $418.3M in fiscal 2024. Over the twelve months to 30 June 2026 it was $375.3M. Over the past ten years it has ranged from −$73.5M (fiscal 2015) to $418.3M (fiscal 2024); the current reading is higher than 91% of that period. Insulet Corporation ranks 13th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $247.1M | (40.93%) |
| FY2024 | $418.3M | 102.76% |
| FY2023 | $206.3M | 4,384.78% |
| FY2022 | $4.6M | (72.62%) |
| FY2021 | $16.8M | 147.06% |
| FY2020 | $6.8M | (41.38%) |
| FY2019 | $11.6M | 251.52% |
| FY2018 | $3.3M | — |
| FY2017 | −$26.8M | — |
| FY2016 | −$28.9M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $95.0M | 4.28% |
| Mar 2026 | $91.1M | (10.33%) |
| Dec 2025 | $101.6M | 15.98% |
| Sep 2025 | $87.6M | 289.33% |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| GMED Globus Medical, Inc. compare | $535.4M |
| PODD Insulet Corporation | $375.3M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $318.3M |
| BIO Bio-Rad Laboratories, Inc. compare | $318.3M |
| PEN Penumbra, Inc. compare | $160.6M |
| HAE Haemonetics Corporation compare | $96.3M |
| BRKR Bruker Corporation compare | −$64.5M |
| GKOS Glaukos Corporation compare | −$188.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on PODD
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement